IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2017-12, Vol.28, p.xi1-xi2 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | xi2 |
|---|---|
| container_issue | |
| container_start_page | xi1 |
| container_title | Annals of oncology |
| container_volume | 28 |
| creator | Miller, M. Sahin, U. Derhovanessian, E. Kloke, B-P Simon, P. Bukur, V. Albrecht, C. Paruzynski, A. Löwer, M. Kuhn, A. Schreeb, K. Attig, S. Brueck, A Kemmer Bolte, S. Grabbe, S. Höller, C. Utikal, J. Huber, C. Loquai, C. Türeci, Ö |
| description | |
| doi_str_mv | 10.1093/annonc/mdx712.003 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx712_003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419328625</els_id><sourcerecordid>S0923753419328625</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3253-f09aedf3446530254ee4fdf1848e5c613fb688932242f1e33ad6bd009c7dbbb23</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMoOKc_wLv8gW75aLtGr8qYOtjczeZtSJOTLdKmI-mGgj_ejnrtzXnhvDyHw4PQIyUTSgSfKu9br6eN-ZpRNiGEX6ERzXKRFCSl12hEBOPJLOPpLbqL8ZMQkgsmRuhn-VHO8Xq3Ld8368UTLrF1IXaJ88nh1CiPjwcVAS-xrp13WtW4C-4yVdhD5_weO2_c2ZlTv2xOnfId9tD24fbgI7ZtwN0BegpU10DfthY3UCvfNuoe3VhVR3j4yzHavSy287dktXldzstVojnLeGKJUGAsT9M844RlKUBqjaVFWkCmc8ptlReF4IylzFLgXJm8MoQIPTNVVTE-RnS4q0MbYwArj8E1KnxLSuRFnxz0yUGf7PX1zPPAQP_Y2UGQUTvwGowLoDtpWvcP_Qtlcnvk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Miller, M. ; Sahin, U. ; Derhovanessian, E. ; Kloke, B-P ; Simon, P. ; Bukur, V. ; Albrecht, C. ; Paruzynski, A. ; Löwer, M. ; Kuhn, A. ; Schreeb, K. ; Attig, S. ; Brueck, A Kemmer ; Bolte, S. ; Grabbe, S. ; Höller, C. ; Utikal, J. ; Huber, C. ; Loquai, C. ; Türeci, Ö</creator><creatorcontrib>Miller, M. ; Sahin, U. ; Derhovanessian, E. ; Kloke, B-P ; Simon, P. ; Bukur, V. ; Albrecht, C. ; Paruzynski, A. ; Löwer, M. ; Kuhn, A. ; Schreeb, K. ; Attig, S. ; Brueck, A Kemmer ; Bolte, S. ; Grabbe, S. ; Höller, C. ; Utikal, J. ; Huber, C. ; Loquai, C. ; Türeci, Ö</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdx712.003</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2017-12, Vol.28, p.xi1-xi2</ispartof><rights>2017 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3253-f09aedf3446530254ee4fdf1848e5c613fb688932242f1e33ad6bd009c7dbbb23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Miller, M.</creatorcontrib><creatorcontrib>Sahin, U.</creatorcontrib><creatorcontrib>Derhovanessian, E.</creatorcontrib><creatorcontrib>Kloke, B-P</creatorcontrib><creatorcontrib>Simon, P.</creatorcontrib><creatorcontrib>Bukur, V.</creatorcontrib><creatorcontrib>Albrecht, C.</creatorcontrib><creatorcontrib>Paruzynski, A.</creatorcontrib><creatorcontrib>Löwer, M.</creatorcontrib><creatorcontrib>Kuhn, A.</creatorcontrib><creatorcontrib>Schreeb, K.</creatorcontrib><creatorcontrib>Attig, S.</creatorcontrib><creatorcontrib>Brueck, A Kemmer</creatorcontrib><creatorcontrib>Bolte, S.</creatorcontrib><creatorcontrib>Grabbe, S.</creatorcontrib><creatorcontrib>Höller, C.</creatorcontrib><creatorcontrib>Utikal, J.</creatorcontrib><creatorcontrib>Huber, C.</creatorcontrib><creatorcontrib>Loquai, C.</creatorcontrib><creatorcontrib>Türeci, Ö</creatorcontrib><title>IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kF1LwzAUhoMoOKc_wLv8gW75aLtGr8qYOtjczeZtSJOTLdKmI-mGgj_ejnrtzXnhvDyHw4PQIyUTSgSfKu9br6eN-ZpRNiGEX6ERzXKRFCSl12hEBOPJLOPpLbqL8ZMQkgsmRuhn-VHO8Xq3Ld8368UTLrF1IXaJ88nh1CiPjwcVAS-xrp13WtW4C-4yVdhD5_weO2_c2ZlTv2xOnfId9tD24fbgI7ZtwN0BegpU10DfthY3UCvfNuoe3VhVR3j4yzHavSy287dktXldzstVojnLeGKJUGAsT9M844RlKUBqjaVFWkCmc8ptlReF4IylzFLgXJm8MoQIPTNVVTE-RnS4q0MbYwArj8E1KnxLSuRFnxz0yUGf7PX1zPPAQP_Y2UGQUTvwGowLoDtpWvcP_Qtlcnvk</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Miller, M.</creator><creator>Sahin, U.</creator><creator>Derhovanessian, E.</creator><creator>Kloke, B-P</creator><creator>Simon, P.</creator><creator>Bukur, V.</creator><creator>Albrecht, C.</creator><creator>Paruzynski, A.</creator><creator>Löwer, M.</creator><creator>Kuhn, A.</creator><creator>Schreeb, K.</creator><creator>Attig, S.</creator><creator>Brueck, A Kemmer</creator><creator>Bolte, S.</creator><creator>Grabbe, S.</creator><creator>Höller, C.</creator><creator>Utikal, J.</creator><creator>Huber, C.</creator><creator>Loquai, C.</creator><creator>Türeci, Ö</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201712</creationdate><title>IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma</title><author>Miller, M. ; Sahin, U. ; Derhovanessian, E. ; Kloke, B-P ; Simon, P. ; Bukur, V. ; Albrecht, C. ; Paruzynski, A. ; Löwer, M. ; Kuhn, A. ; Schreeb, K. ; Attig, S. ; Brueck, A Kemmer ; Bolte, S. ; Grabbe, S. ; Höller, C. ; Utikal, J. ; Huber, C. ; Loquai, C. ; Türeci, Ö</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3253-f09aedf3446530254ee4fdf1848e5c613fb688932242f1e33ad6bd009c7dbbb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miller, M.</creatorcontrib><creatorcontrib>Sahin, U.</creatorcontrib><creatorcontrib>Derhovanessian, E.</creatorcontrib><creatorcontrib>Kloke, B-P</creatorcontrib><creatorcontrib>Simon, P.</creatorcontrib><creatorcontrib>Bukur, V.</creatorcontrib><creatorcontrib>Albrecht, C.</creatorcontrib><creatorcontrib>Paruzynski, A.</creatorcontrib><creatorcontrib>Löwer, M.</creatorcontrib><creatorcontrib>Kuhn, A.</creatorcontrib><creatorcontrib>Schreeb, K.</creatorcontrib><creatorcontrib>Attig, S.</creatorcontrib><creatorcontrib>Brueck, A Kemmer</creatorcontrib><creatorcontrib>Bolte, S.</creatorcontrib><creatorcontrib>Grabbe, S.</creatorcontrib><creatorcontrib>Höller, C.</creatorcontrib><creatorcontrib>Utikal, J.</creatorcontrib><creatorcontrib>Huber, C.</creatorcontrib><creatorcontrib>Loquai, C.</creatorcontrib><creatorcontrib>Türeci, Ö</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miller, M.</au><au>Sahin, U.</au><au>Derhovanessian, E.</au><au>Kloke, B-P</au><au>Simon, P.</au><au>Bukur, V.</au><au>Albrecht, C.</au><au>Paruzynski, A.</au><au>Löwer, M.</au><au>Kuhn, A.</au><au>Schreeb, K.</au><au>Attig, S.</au><au>Brueck, A Kemmer</au><au>Bolte, S.</au><au>Grabbe, S.</au><au>Höller, C.</au><au>Utikal, J.</au><au>Huber, C.</au><au>Loquai, C.</au><au>Türeci, Ö</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma</atitle><jtitle>Annals of oncology</jtitle><date>2017-12</date><risdate>2017</risdate><volume>28</volume><spage>xi1</spage><epage>xi2</epage><pages>xi1-xi2</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdx712.003</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2017-12, Vol.28, p.xi1-xi2 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdx712_003 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A21%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IVAC%20MUTANOME:%20A%20first-in-human%20phase%20I%20clinical%20trial%20targeting%20individual%20mutant%20neoantigens%20for%20the%20treatment%20of%20melanoma&rft.jtitle=Annals%20of%20oncology&rft.au=Miller,%20M.&rft.date=2017-12&rft.volume=28&rft.spage=xi1&rft.epage=xi2&rft.pages=xi1-xi2&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdx712.003&rft_dat=%3Celsevier_cross%3ES0923753419328625%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419328625&rfr_iscdi=true |